so responding to myself here key points on Aroa yearly...

so responding to myself here key points on Aroa yearly report;
81% yoy growth to 39.7 million NZD, 220 employees, 76% margin product; released two new products this year
56 million nzd cash balance (due to recent 50 million cap raise)
they have a huge focus on growing the US mkt have 33 field sales reps and 7 inside sales reps just for the US
they mention they based their tech off sheep forgut skin scaffold removing all animal cells to reduce risk of body rejecting
looks to be selling well

gives me confidence PNV will also be a good end of year

i also saw a much smaller company Osteocare, also asx listed reporting increased earning due to increased surgeries and reduced impact of covid. so this would support a strong finish for PNV given they also require access to hospitals and surgeries taking place